U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07866248) titled 'Evaluation of Polidocanol Foam Sclerotherapy in Symptomatic Internal Hemorrhoids: A Prospective Study' on Oct. 04.
Brief Summary: To evaluate the efficacy, durability, safety, and clinical/endoscopic outcomes of standardized 3% polidocanol foam sclerotherapy in patients with symptomatic grade II-III internal hemorrhoids over a 12-month follow-up period.
Study Start Date: Oct. 01
Study Type: INTERVENTIONAL
Condition:
Internal Piles Sclerotherapy
Internal Hemorrhoids
Intervention:
PROCEDURE: Standardized 3% Polidocanol Foam Sclerotherapy
3% polidocanol foam, Sims position, Open-ended anoscope, use of 20-G needle, Injection above...